IN2013MU01250A - - Google Patents

Info

Publication number
IN2013MU01250A
IN2013MU01250A IN1250MU2013A IN2013MU01250A IN 2013MU01250 A IN2013MU01250 A IN 2013MU01250A IN 1250MU2013 A IN1250MU2013 A IN 1250MU2013A IN 2013MU01250 A IN2013MU01250 A IN 2013MU01250A
Authority
IN
India
Prior art keywords
methylphenidate
salts
release
composition
pharmaceutical compositions
Prior art date
Application number
Other languages
English (en)
Inventor
Girish Kumar Jain
Rahul Sudhakar Dabre
Jitendrakumar Chordiya
Inderjeetsingh Huda
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN1250MU2013 priority Critical patent/IN2013MU01250A/en
Priority to PCT/IB2014/060084 priority patent/WO2014174388A1/en
Publication of IN2013MU01250A publication Critical patent/IN2013MU01250A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1250MU2013 2013-03-29 2014-03-24 IN2013MU01250A (lt)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN1250MU2013 IN2013MU01250A (lt) 2013-03-29 2014-03-24
PCT/IB2014/060084 WO2014174388A1 (en) 2013-03-29 2014-03-24 Modified release pharmaceutical compositions of methylphenidate or salts thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1250MU2013 IN2013MU01250A (lt) 2013-03-29 2014-03-24

Publications (1)

Publication Number Publication Date
IN2013MU01250A true IN2013MU01250A (lt) 2015-04-17

Family

ID=54395650

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1250MU2013 IN2013MU01250A (lt) 2013-03-29 2014-03-24

Country Status (1)

Country Link
IN (1) IN2013MU01250A (lt)

Similar Documents

Publication Publication Date Title
PH12019502355A1 (en) Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
MX2013011908A (es) Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank.
IN2015DN01156A (lt)
PH12015500724A1 (en) 1, 2, 4-triazine derivatives for the treatment of viral infections
MX2013012053A (es) Inhibidores de replicacion viral, su proceso de preparacion y sus usos terapeuticos.
MX2013011691A (es) Inhibidores de la replicacion viral, su proceso de preparacion y sus usos terapeuticos.
MX367926B (es) Composicion farmaceutica para liberacion sostenida de lanreotida.
MX342119B (es) 2-oxi-quinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
IN2014DN09437A (lt)
MX364704B (es) Inhibidores de replicacion viral, su proceso de preparacion y sus usos terapeuticos.
GB201115977D0 (en) Neurodevelopmental disorders
MX2013002295A (es) 1-oxo-dihidroisoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
IN2013MU01247A (lt)
IN2013MU01244A (lt)
IN2013MU01248A (lt)
IN2013MU01250A (lt)
IN2013MU01249A (lt)
IN2013MU01246A (lt)
IN2013MU01245A (lt)
IN2013MU01240A (lt)
IN2013MU01241A (lt)
IN2013MU01242A (lt)
IN2013MU01243A (lt)
IN2013MU01239A (lt)